FY22 Investor Presentation

PROFIT & LOSS STATEMENT UNDERLYING¹ STATUTORY FY22 FY21 Change Revenue $72.66m $58.04m 24% FY22 $72.66m FY21 Change $58.38m 24% Cost of Sales ($47.43m) ($35.65m) 33% ($47.43m) ($35.65m) 33% Gross Profit $25.22m $22.39m 13% $25.22m $22.73m 13% Other Income Operating Expenses EBITDA $0.53m $0.63m -16% $0.61m $1.29m -53% ($21.90m) ($19.96m) 10% ($20.15m) ($17.65m) 14% $3.85m $3.06m 26% $5.69m $6.37m -11% Depreciation and Amortisation ($3.85m) ($3.94m) 2% ($5.44m) ($5.47m) -1% Share-based payments expense ($0.68m) ($0.22m) n.m ($0.68m) ($0.22m) n.m Impairment recovery/(expense) $- $- n.a $0.40m ($0.40m) n.m Fair Value Gain on Financial n.a $- $0.12m $- n.a Asset Profit on Sale of Asset $- n.a $0.00m $0.20m n.m EBIT ($0.68m) ($1.10m) n.m $0.10m $0.49m -73% Net Finance income/(expense) ($0.52m) ($1.30m) 60% ($0.78m) ($1.99m) n.m Embedded derivative non cash $- $- n.a $1.14m ($2.24m) n.m financing gain/(cost) Net Profit/(Loss) Before Tax ($1.20m) ($2.40m) 50% $0.46m ($3.75m) n.m Income Tax Benefit Net Profit/(Loss) After tax $0.36m ($0.84m) $0.72m -50% $1.12m ($1.68m) n.m. $1.59m $1.89m ($1.86m) -19% n.m. 1. FY22 Underlying adjusted for the impact of AASB16 Leasing Standard and Impairment Reversal. FY21 Underlying adjusted for the impact of AASB16, Gain on Sale and Government Incentives received in the prior period. n.a - Not Applicable FY22 Investor Presentation 24 n.m - Not Meaningful Note - may not add through due to rounding differences

View entire presentation